Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Faeth Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +8 vs. Q2 2021
- Shares held
- 3.53M
- +1.21M (+51.9%) vs. Q2 2021
- Total value
- $37.1M
- +$14.4M (+63.6%) vs. Q2 2021
- New holders
- 14
- 16 more added
- Sold out
- 6
- 9 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $68.0M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.2K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.43M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 1,000,322 | $10.5M | 0.00% | +636,856+175.2% | Added |
| Vanguard Group Inc | 746,759 | $7.86M | 0.00% | +359,006+92.6% | Added |
| Geode Capital Management, LLC | 273,978 | $2.88M | 0.00% | +132,169+93.2% | Added |
| Millennium Management LLC | 258,659 | $2.72M | 0.00% | +258,659 | New |
| JPMorgan Chase & Co | 169,340 | $1.78M | 0.00% | −9,738−5.4% | Reduced |
| State Street Corp | 168,031 | $1.77M | 0.00% | +68,031+68.0% | Added |
| Northern Trust Corp | 160,758 | $1.69M | 0.00% | +85,747+114.3% | Added |
| Citadel Advisors LLC | 123,258 | $1.30M | 0.00% | −160,409−56.5% | Reduced |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $1.05M | 0.03% | 00.0% | Unchanged |
| Truist Financial Corp | 70,374 | $740.0K | 0.00% | +70,374 | New |
| Nuveen Asset Management, LLC | 56,349 | $548.0K | 0.00% | +43,813+349.5% | Added |
| Moore Capital Management, LP | 49,341 | $519.0K | 0.01% | −78,159−61.3% | Reduced |
| Bank of New York Mellon Corp | 47,066 | $495.0K | 0.00% | +28,635+155.4% | Added |
| Charles Schwab Investment Management Inc | 46,579 | $491.0K | 0.00% | −8,386−15.3% | Reduced |
| Alps Advisors Inc | 37,484 | $394.0K | 0.00% | −2,802−7.0% | Reduced |
| Mission Creek Capital Partners, Inc. | 32,784 | $345.0K | 0.06% | +32,784 | New |
| Tao Capital Management LP | 32,784 | $345.0K | 0.09% | +32,784 | New |
| Pura Vida Investments, LLC | 22,603 | $238.0K | 0.02% | 00.0% | Unchanged |
| Rhumbline Advisers | 16,579 | $174.0K | 0.00% | +16,579 | New |
| BFT Financial Group, LLC | 14,845 | $156.0K | 0.03% | +14,845 | New |
| Manufacturers Life Insurance Company, The | 13,478 | $142.0K | 0.00% | +13,478 | New |
| SG Americas Securities, LLC | 12,614 | $133.0K | 0.00% | +12,614 | New |
| Deutsche Bank AG | 12,021 | $126.0K | 0.00% | +7,368+158.3% | Added |
| American International Group, Inc. | 11,437 | $120.0K | 0.00% | +7,171+168.1% | Added |
| California State Teachers Retirement System | 11,291 | $119.0K | 0.00% | +762+7.2% | Added |
| Jane Street Group, LLC | 10,773 | $113.0K | 0.00% | +10,773 | New |
| Bank of America Corp | 8,514 | $90.0K | 0.00% | −3,161−27.1% | Reduced |
| New York State Common Retirement Fund | 5,413 | $57.0K | 0.00% | +17+0.3% | Added |
| Morgan Stanley | 3,315 | $35.0K | 0.00% | −104,411−96.9% | Reduced |
| Royal Bank of Canada | 2,411 | $25.0K | 0.00% | +1,732+255.1% | Added |
| Citigroup Inc | 2,409 | $25.0K | 0.00% | +2,047+565.5% | Added |
| Legal & General Group Plc | 1,674 | $18.0K | 0.00% | +1,081+182.3% | Added |
| Ameritas Investment Partners, Inc. | 1,602 | $17.0K | 0.00% | +982+158.4% | Added |
| UBS Group AG | 1,009 | $11.0K | 0.00% | +315+45.4% | Added |
| Tower Research Capital LLC (TRC) | 775 | $8.00K | 0.00% | −635−45.0% | Reduced |
| Investment Research & Advisory Group, Inc. | 1,400 | $5.00K | 0.00% | +1,400 | New |
| Banque Cantonale Vaudoise | 300 | $3.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 61 | $1.00K | 0.00% | −11,020−99.4% | Reduced |
| US Bancorp | 91 | $1.00K | 0.00% | +91 | New |
| Signaturefd, LLC | 142 | $1.00K | 0.00% | +142 | New |
| Parallel Advisors, LLC | 54 | $1.00K | 0.00% | +54 | New |
| Lindbrook Capital, LLC | 27 | $0 | 0.00% | +27 | New |
| Formula Growth Ltd | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −46,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −28,111−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −23,200−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −18,551−100.0% | Sold out |